← Scroll for more →
Vanda Pharmaceuticals Inc. (VNDA)
Pharmaceutical Preparations
Latest Price
$3.99
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
3.66
P/B Ratio
1.09
Valuation metrics
adjust assumptions →Norm. op. income: $6M (median of 7yr)
Tax rate: 35%
Discount rate: 10%
Growth assumption: zero (EPV is a no-growth value)
Earnings Power Value
$2.13
46% downside
Base FCF: $31M (median of recent 5yr)
Growth: -2%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$6.90
+75% upside
Institutional Ownership
79.2% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 7.65M | $46.0M | 12.66% | +377.7K | 2026-06-30 |
| State Street Corp | 3.52M | $21.0M | 5.82% | +500.8K | 2026-06-30 |
| AQR Capital Management LLC | 3.50M | $21.0M | 5.79% | +1.89M | 2026-06-30 |
| Renaissance Technologies LLC | 3.44M | $21.0M | 5.69% | -318.2K | 2026-06-30 |
| Vanguard Capital Management LLC | 2.52M | $15.0M | 4.18% | +42.5K | 2026-06-30 |
| AIGH Capital Management LLC | 2.04M | $12.0M | 3.38% | -705.8K | 2026-06-30 |
| Dimensional Fund Advisors LP | 1.73M | $10.0M | 2.86% | -44.2K | 2026-06-30 |
| Millennium Management LLC | 1.60M | $9.0M | 2.65% | -278.2K | 2026-06-30 |
| Geode Capital Management, LLC | 1.48M | $9.0M | 2.45% | +40.8K | 2026-06-30 |
| Two Sigma Investments, LP | 1.35M | $8.0M | 2.23% | -- | 2026-06-30 |